跳至主要内容
临床试验/NCT01691937
NCT01691937已完成2 期

Continuous Right Thoracic Paravertebral Block on Postoperative Pain After Right Lobe Hepatectomy

Huazhong University of Science and Technology1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2012年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
48
试验地点
1
主要终点
The cumulative opioid consumption

研究概览

简要总结

Patients often experience moderate to severe postoperative pain, especially during the first hours after hepatectomy. Systemic opioids given with patient-controlled analgesia has be used after hepatectomy in many medical center(Aubrun, Monsel et al. 2001; Aubrun, Salvi et al. 2005), but the analgesic effect can be limited and undesirable side effects may occur.

A case report described that right thoracic paravertebral block reduced pain and analgesic requirements after right lobe hepatectomy(Ho, Karmakar et al. 2004). Compared with epidural analgesia, thoracic paravertebral block probably carries a much lower risk of spinal haematoma in the presence of moderate haemostatic deficiencies (Richardson and Lonnqvist 1998; Karmakar 2001).

We therefore designed a prospective, randomized, subject and assessor blinded, parallel-group, placebo controlled study to test the hypothesis that continuous right thoracic paravertebral analgesia decreases opioid consumption during the first 24 h after right lobe hepatectomy in patients receiving i.v. patient-controlled analgesia (PCA) with sufentanil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 18-70 yrs
  • •American Society of Anesthesiologists physical statusⅠ-Ⅲ
  • •Undergo right lobe hepatectomy
  • •Informed consent

排除标准

  • •A known allergy to the drugs being used
  • •Coagulopathy, on anticoagulants
  • •Analgesics intake, history of substance abuse
  • •Participating in the investigation of another experimental agent
  • •Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

研究组 & 干预措施

Placebo PVB + PCA

Placebo Comparator

Continuous Paravertebral Block with Saline and Patient-controlled analgesia with sufentanil

干预措施: Continuous Paravertebral Block with Saline (Procedure)

PVB + PCA

Experimental

Continuous Paravertebral block with ropivacaine and Patient-controlled analgesia with sufentanil

干预措施: Continuous Paravertebral block with ropivacaine (Procedure)

PVB + PCA

Experimental

Continuous Paravertebral block with ropivacaine and Patient-controlled analgesia with sufentanil

干预措施: Patient-controlled analgesia with sufentanil (Procedure)

Placebo PVB + PCA

Placebo Comparator

Continuous Paravertebral Block with Saline and Patient-controlled analgesia with sufentanil

干预措施: Patient-controlled analgesia with sufentanil (Procedure)

结局指标

主要结局

The cumulative opioid consumption

时间窗: At 24 postoperative hours

次要结局

  • The pain scores determined by the numeric rating scale (NRS, 0-10)(At 1, 4, 8, 16, and 24 hrs after the surgery)
  • Incidence of postoperative nausea and vomiting(Up to 24 postoperative hrs)
  • Incidence of postoperative respiratory depression(Up to 24 postoperative hrs)
  • Intraoperative bleeding(Up to 4 hours)
  • Postoperative hospital length of stay(Up to 6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Mei

Associate Prof.

Huazhong University of Science and Technology

研究点 (1)

Loading locations...

相似试验